Clinical Trial Update: DOuBLED - Doubling Outcomes by Lung Cancer Early Diagnosis

View source ↗

Summary

A completed clinical trial update from AstraZeneca titled DOuBLED (Doubling Outcomes by Lung Cancer Early Diagnosis) evaluating early diagnosis of lung cancer i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Pulmonary Nodules

Snippet

Sponsor: AstraZeneca | Conditions: Pulmonary Nodules | Status: COMPLETED